These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15100163)

  • 21. Inhibition of gastric emptying is a physiological action of cholecystokinin.
    Debas HT; Farooq O; Grossman MI
    Gastroenterology; 1975 May; 68(5 Pt 1):1211-7. PubMed ID: 1126597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cholecystokinin in the regulation of gastrointestinal motility.
    Grider JR
    J Nutr; 1994 Aug; 124(8 Suppl):1334S-1339S. PubMed ID: 8064380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
    Chey WY; Jin HO; Lee MH; Sun SW; Lee KY
    Am J Gastroenterol; 2001 May; 96(5):1499-506. PubMed ID: 11374689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical endocrinology and metabolism. Cholecystokinin.
    Rehfeld JF
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexloxiglumide Rotta Research Lab.
    Varga G
    Curr Opin Investig Drugs; 2002 Apr; 3(4):621-6. PubMed ID: 12090734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility.
    Romański KW
    Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning of cholecystokinin (CCK) and CCK-A receptor and mechanism of CCK-induced gastrointestinal motility in Suncus murinus.
    Takemi S; Honda W; Yokota N; Sekiya H; Miura T; Wada R; Sakai T; Sakata I
    Gen Comp Endocrinol; 2022 Oct; 327():114074. PubMed ID: 35700795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motility disorders in the irritable bowel syndrome.
    Lind CD
    Gastroenterol Clin North Am; 1991 Jun; 20(2):279-95. PubMed ID: 2066153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystokinin hyperresponsiveness in functional dyspepsia.
    Chua AS; Keeling PW
    World J Gastroenterol; 2006 May; 12(17):2688-93. PubMed ID: 16718754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.
    Fornai M; Colucci R; Antonioli L; Crema F; Buccianti P; Chiarugi M; Baschiera F; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M
    Br J Pharmacol; 2007 Aug; 151(8):1246-53. PubMed ID: 17572695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of colonic motility by cholecystokinin.
    Mangel AW; Brazer SR; Smith JW; Fitz JG; Taylor IL
    Ann Med; 1992 Oct; 24(5):341-2. PubMed ID: 1418916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of postprandial intestinal motility and release of cholecystokinin by polyamines in rats.
    Fioramonti J; Fargeas MJ; Bertrand V; Pradayrol L; Buéno L
    Am J Physiol; 1994 Dec; 267(6 Pt 1):G960-5. PubMed ID: 7810663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders.
    Jensen RT
    Pharmacol Toxicol; 2002 Dec; 91(6):333-50. PubMed ID: 12688377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit.
    O'Brien MD; Camilleri M; Thomforde GM; Wiste JA; Hanson RB; Zinsmeister AR
    Dig Dis Sci; 1997 Jan; 42(1):26-33. PubMed ID: 9009112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat.
    Rodríguez-Membrilla A; Martínez V; Vergara P
    J Pharmacol Exp Ther; 1995 Oct; 275(1):486-93. PubMed ID: 7562590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles for CCK1 and 5-HT3 receptors in the effects of CCK on presympathetic vasomotor neuronal discharge in the rat.
    Saita M; Verberne AJ
    Br J Pharmacol; 2003 May; 139(2):415-23. PubMed ID: 12770947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.